Rates of Treatment Eligibility in Follow-Up of Patients with Chronic Hepatitis B (CHB) Across Various Clinical Settings Who Were Initially Ineligible at Presentation.
about
Serum metabolomic signatures discriminate early liver inflammation and fibrosis stages in patients with chronic hepatitis B.Community-Based Services to Improve Testing and Linkage to Care Among Non-U.S.-Born Persons with Chronic Hepatitis B Virus Infection - Three U.S. Programs, October 2014-September 2017.
P2860
Rates of Treatment Eligibility in Follow-Up of Patients with Chronic Hepatitis B (CHB) Across Various Clinical Settings Who Were Initially Ineligible at Presentation.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Rates of Treatment Eligibility ...... ly Ineligible at Presentation.
@en
type
label
Rates of Treatment Eligibility ...... ly Ineligible at Presentation.
@en
prefLabel
Rates of Treatment Eligibility ...... ly Ineligible at Presentation.
@en
P2093
P2860
P1476
Rates of Treatment Eligibility ...... ly Ineligible at Presentation.
@en
P2093
Christopher Wong
Clifford Wong
Huy N Trinh
Lindsay A Uribe
Long H Nguyen
Mindie H Nguyen
Nghia Nguyen
P2860
P2888
P304
P356
10.1007/S10620-015-3982-4
P577
2015-12-10T00:00:00Z